CALLIDITAS THERAPEUTICS AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 208.2 SEK | +0.10% |
|
+81.83% | +63.81% |
| May. 31 | Citigroup Downgrades Calliditas Therapeutics to Neutral From Buy, Price Target at $39 | MT |
| May. 31 | Calliditas Partner Secures European Panel Backing for Rare Kidney Disease Treatment | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 229.21 | 252.46 | 265.84 |
| Spread/Res. | -9.17% | -17.53% | -21.68% |
| Spread/Supp. | +51.31% | +51.31% | +59.30% |
| Support | 137.60 | 137.60 | 130.70 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- CALTX Stock
- Charts Calliditas Therapeutics AB
